SIREN : 479154734
GENESYL is a French company founded 21 years ago, specialized in the sector Activités des sociétés holding. Based in NICE (06000), this company of category PME shows in 2024 a revenue of -110 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -110 000 € | 80 833 € | 150 000 € | 69 167 € | N/C | N/C | N/C | 135 000 € | 100 000 € |
| Net income | 313 722 € | 21 526 € | 67 156 € | 51 050 € | -3 313 € | -18 021 € | 115 369 € | 115 753 € | 162 486 € |
| EBITDA | -146 159 € | 37 871 € | 119 307 € | 52 595 € | -2 782 € | -17 355 € | -44 157 € | 112 188 € | 84 148 € |
| Net margin | -285.2% | 26.6% | 44.8% | 73.8% | N/C | N/C | N/C | 85.7% | 162.5% |
In 2024, GENESYL generates positive net income of 314 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 162 k€ -> 314 k€.
-110 000 €
-110 000 €
-146 159 €
-147 805 €
313 722 €
132.9%
The debt ratio (= Financial debt / Equity x 100) stands at 99%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
98.652%
26.055%
-286.614%
0.512
36.6%
In 2024, the debt ratio of GENESYL (98.65) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of GENESYL (26.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of GENESYL (0.51) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 135.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
135.128
-67.465
In 2024, the liquidity ratio of GENESYL (135.13) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of GENESYL (-67.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 10 days. Favorable situation: supplier credit is longer than customer credit by 10 days. WCR is negative (-230 days): operations structurally generate cash. Notable WCR improvement over the period (-92%), freeing up cash.
70 407 €
0 j
10 j
0 j
-230 j
Based on 54 transactions of similar company sales
in 2024,
the value of GENESYL is estimated at
458 022 €
(range 292 118€ - 2 343 020€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GENESYL with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of GENESYL in 2024 is -110 k€.
Yes, GENESYL generated a net profit of 314 k€ in 2024.
The headquarters of GENESYL is located in NICE (06000), in the department Alpes-Maritimes.
The tax return of GENESYL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GENESYL operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.